The Cancer Letter

Inside information on cancer research and drug development

Letter To The Editor

A reminder: The real goal is saving lives

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
BYLINEDOWNLOAD PDFTABLE OF CONTENTS

Dear Editor,

I was disappointed to see that you reported on the results of the IMpassion 131 trial, without context. [The Cancer Letter, Sept. 4, 2020]

I often see stories touting increased funding at NCI and changes in the payline. However, these are not the ultimate goals we are all working toward. More money, more research, and more researchers are simply the tools to achieve the real goal: saving lives. Is the system set up to accomplish the real goal? I continue to question that.

To access this subscriber-only content please log in or renew your subscription.

Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.

Login Subscribe
Byline
Frances M. Visco, JD
President, National Breast Cancer Coalition
Table of Contents

YOU MAY BE INTERESTED IN

Guest Editorial

Call to action: To address Black cancer disparities, focus on research prioritization and clinical studies inclusion
Minority Cancer Awareness Week

People of African ancestry (Black/African American) have some of the worst cancer incidence and greatest mortality, compared to white and other racial and ethnic populations in the U.S. On average, Black persons are 1.5 times more likely to have cancer and >2X more likely to die from cancer compared to whites. xxx:more
By Kimlin Tam Ashing, Nadine J. Barrett, Kim F. Rhoads, Folakemi T. Odedina, Hayley S. Thompson and Camille C. R. Ragin
Byline
Frances M. Visco, JD
President, National Breast Cancer Coalition
Table of Contents

Login

Looking for IP Login?